High expression of MLH1, as shown by immunohistochemistry was an independent protective factor for 253 lymph-node metastases (OR: 0.969, 95% CI 0.945, 0.994, P = 0.015) (Table 4). Here, MLH1 is linked to metastatic malignant neoplasm in the lymph nodes.